These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7039130)

  • 41. [Vasodilators in the treatment of cardiac insufficiency (author's transl)].
    Laaban JP; D'Orbcastel OR
    Poumon Coeur; 1979; 35(5):293-302. PubMed ID: 537977
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure.
    Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W
    Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medical therapy and prognosis in chronic heart failure. Lessons from clinical trials.
    Ramahi TM; Lee FA
    Cardiol Clin; 1995 Feb; 13(1):5-26. PubMed ID: 7796432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure.
    Elkayam U; Lejemtel TH; Mathur M; Ribner HS; Frishman WH; Strom J; Sonnenblick EH
    Am J Cardiol; 1979 Sep; 44(3):540-5. PubMed ID: 474434
    [No Abstract]   [Full Text] [Related]  

  • 45. [Prolonged hemodynamic effects of pentaerythrityl tetranitrate combined with piridoxylate].
    Baudet M; Hericotte P
    Sem Hop; 1983 Mar; 59(10):683-5. PubMed ID: 6304889
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Usefulness of vasodilators in congestive cardiac insufficiency: studies with prazosin].
    Conti CR; Miles D; Mehta J
    Cardiology; 1980; 66 Suppl 2():186-92. PubMed ID: 7285029
    [No Abstract]   [Full Text] [Related]  

  • 47. [Evaluation of prazosin in chronic cardiac insufficiency by external chronometry of the left ventricle].
    Sánchez Domínguez J; Largo F; Barciela R; Urbina FJ; Villa JG
    Rev Clin Esp; 1983 Mar; 168(5):343-6. PubMed ID: 6867409
    [No Abstract]   [Full Text] [Related]  

  • 48. Vasodilator therapy.
    Sutton FJ
    Am J Med; 1986 Feb; 80(2B):54-8. PubMed ID: 3511697
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The effect of oral prazosin therapy on severe cardiac insufficiency].
    Józan M; Tarján J; Tordasi E; Wágner G; Bordás I; Jávor A; Kovács S
    Orv Hetil; 1983 May; 124(21):1259-61. PubMed ID: 6877803
    [No Abstract]   [Full Text] [Related]  

  • 50. Danger of withdrawal of vasodilator therapy in patients with chronic heart-failure.
    Hanley SP; Cowley A; Hampton JR
    Lancet; 1980 Apr; 1(8171):735-6. PubMed ID: 6103157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hemodynamic effects at rest and during exercise in long-term treatment with prazosin in chronic congestive heart failure.
    Westheim A; Koss A; Sivertssen E
    Acta Med Scand; 1986; 219(5):449-53. PubMed ID: 3526819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hemodynamic effects and clinical observations on prazosin in treating chronic refractory congestive heart failure].
    Shen LH; Ku FS; Liu QS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1984 Dec; 12(4):244-7, 315. PubMed ID: 6544203
    [No Abstract]   [Full Text] [Related]  

  • 53. Ambulatory prazosin treatment of chronic congestive heart failure: development of late tolerance reversible by higher dosage and interrupted substitution therapy.
    Awan NA; Lee G; DeMaria AN; Mason DT
    Am Heart J; 1981 May; 101(5):541-7. PubMed ID: 7223594
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A review of the long-term effects of prazosin and hydralazine in chronic congestive heart failure.
    Rutishauser W
    Eur Heart J; 1983 Jan; 4 Suppl A():149-52. PubMed ID: 6840121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aspects on "traditional" vasodilators in the treatment of chronic heart failure.
    Rydén L; Conradson TB
    Acta Med Scand Suppl; 1986; 707():85-90. PubMed ID: 3526822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of alpha-receptor blockade with prazosin in advanced chronic congestive heart failure.
    Lui HK; Awan NA; Mason DT
    Herz; 1983 Apr; 8(2):65-70. PubMed ID: 6303929
    [No Abstract]   [Full Text] [Related]  

  • 57. [Hemodynamic effects of a single dose of prazosin in 8 cases of mitral or aortic regurgitation].
    Juillard A; Batalla N; Leroy G; Fernandez F; Gerbaux A
    Arch Mal Coeur Vaiss; 1981 Oct; 74(10):1227-32. PubMed ID: 6796026
    [No Abstract]   [Full Text] [Related]  

  • 58. [Adrenergic alpha-receptor blockaders and direct arteriolar vasodilators in treatment of chronic cardiac insufficiency].
    Novikov SV; Mareev VIu
    Ter Arkh; 1983; 55(5):135-40. PubMed ID: 6137073
    [No Abstract]   [Full Text] [Related]  

  • 59. Prazosin in chronic congestive heart failure due to ischemic heart disease.
    Antani JA; Antani NJ; Nanivadekar AS
    Clin Cardiol; 1991 Jun; 14(6):495-500. PubMed ID: 1810687
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term maintenance therapy with prazosin in congestive heart failure.
    Mehta J; Miles D; Iacona M; Conti CR
    Clin Cardiol; 1981 May; 4(3):139-45. PubMed ID: 6790215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.